Research To Practice
Innovative Oncology Education by Neil Love, MD
Latest on-demand programs
-
Oncology Today with Dr Neil Love
The Potential Role of TROP2- and CDH6-Directed Antibody-Drug Conjugates in Gynecologic Cancers
-
R
-
R
-
Nursing Symposium
Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Oral Selective Estrogen Receptor Degraders in Breast Cancer
-
B
-
H
-
M
- +1
-
B
-
Microlearning Activity
New Directions and Approaches in the Management of HER2-Altered Non-Small Cell Lung Cancer
-
J
-
J
-
ASCO Satellite 2026
Cases from the Community: Investigators Discuss the Optimal Management of Chronic Lymphocytic Leukemia
-
B
-
J
-
J
- +2
-
B
-
ASCO Satellite 2026
Consensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Management of Colorectal Cancer
-
A
-
S
-
T
-
A
Upcoming sessions
Integrating New Advances into Community Oncology Practice
Saturday, Aug 22 9:00 AM — 2:20 PM CT
In Person & Webinar Nashville, Tennessee
Ann LaCasce, Farrukh T Awan
+4 more
-
Aug222026Saturday
Integrating New Advances into Community Oncology Practice
In Person & Webinar Nashville, Tennessee ABIM MOC, ABS MOC, ACPE, CME, NCPD -
Aug252026Tuesday
Where We Are, Where We’re Going: Targeting KRAS G12C in Non-Small Cell Lung Cancer
Webinar Online ABIM MOC, ABS MOC, CME -
Aug262026Wednesday
The Implications of Recent Datasets for the Current and Future Management of Gynecologic Cancers — An ASCO 2026 Review
Webinar Online ABIM MOC, ABS MOC, CME
Trusted provider of oncology medical education
Founded and led by medical oncologist Neil Love, MD, the RTP team has extensive experience developing educational programs to bridge the gap between research and patient care.
Our goals are to improve the quality of care received by patients with cancer and to assist physicians and nurses in the complex decision-making surrounding cancer treatment.
Get the RTP app
Listen to Research To Practice’s latest CME/NCPD accredited activities, which feature one-on-one interviews with clinical investigators, case-based discussions, and proceedings from recent symposia.
